Where is Ribo headquartered?

Ribo is located in Kunshan, jiangsu province.

Who invested in Ribo?

Ribo has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Ribo?

Ribo closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

ribolia.com

Ribo

Ribo Bio is a China-based biopharmaceutical company that develops and commercializes small nucleic acid drugs for the treatment of cancer and liver diseases.

Business Model:

Revenue: $5.6M

Employees: 11-50

Geographic Data

Address: No.168 Yuanfeng Road

City: Kunshan

State: jiangsu province

Zip: 215300

Country: CN

Financial Info

Stage:

series c

Raised Last:

$66M

Raised Total:

$142M

Social

Crunchbase

Metrics

9,212,495Website Global Rank

189Website Monthly Traffic

Twitter Followers

Description

Ribo Bio is a China-based biopharmaceutical company that develops and commercializes small nucleic acid drugs for the treatment of cancer and liver diseases.

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
12/2019	Series C		$0	Blue Ocean Capital Group Daxie Yungong Investment Hanyang Capital Legend Capital Pan-Lin Capital SDIC Fund Management Blue Ocean Capital Group Daxie Yungong Investment Hanyang Capital Legend Capital Pan-Lin Capital SDIC Fund Management
9/2020	Series C		$36.7M	SDIC Fund Legend Capital China Venture Capital Fund GL Ventures Panlin Capital Trinity Innovation Everest VC Yungong Jiajie Equity Investment Blue Ocean Capital Hongtao Capital Shanghai Free Trade Zone Equity Fund Management
4/2020	Series C	7	$66.3M	China State-Owned Capital Venture Investment Fund CICC Everest Ventures FTZ Fund GL Ventures Hillhouse Capital Group SAIC Capital China State-Owned Capital Venture Investment Fund CICC Everest Ventures FTZ Fund GL Ventures Hillhouse Capital Group SAIC Capital
3/2017	Series B		$0	China Resources GGV Capital Legend Capital Lotus Lake Ventures Pan-Lin Capital SDIC Fund Management China Resources GGV Capital Legend Capital Lotus Lake Ventures Pan-Lin Capital SDIC Fund Management
1/2014	Series A	1	$7.4M	BVCF BVCF
12/2019	Series C		$29M	Panlin Capital
3/2017	Series B		$39.1M	SDIC Fund Management China Resources TusPark Ventures Legend Capital
7/2022	Series E		$40M	Panlin Capital Trinity Innovation Fund
4/2020	Series C		$66M	CICC Capital Hillhouse Capital SAIC Capital Shanghai Free Trade Zone Equity Fund Management
12/2019	Series C	6	$28.8M	Blue Ocean Capital Group Daxie Yungong Investment Hanyang Capital Legend Capital Pan-Lin Capital SDIC Fund Management Blue Ocean Capital Group Daxie Yungong Investment Hanyang Capital Legend Capital Pan-Lin Capital SDIC Fund Management
3/2017	Series B	6	$39.1M	China Resources GGV Capital Legend Capital Lotus Lake Ventures Pan-Lin Capital SDIC Fund Management China Resources GGV Capital Legend Capital Lotus Lake Ventures Pan-Lin Capital SDIC Fund Management

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details